Trials / Completed
CompletedNCT02402595
Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts
A Phase 1, Single-center, Randomized, Double-blind, Double-dummy, Drug Interaction Study Between AVP-923 and Itraconazole, and Between AVP-786 and Itraconazole in Healthy Adult Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Avanir Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the effects of a potent CYP3A4 inhibitor, itraconazole, on the steady-state PK of AVP-923 and AVP-786.
Detailed description
A Phase 1, single-center, randomized, double-blind, double-dummy drug interaction study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AVP-923 | |
| DRUG | AVP-786 | |
| DRUG | Itraconazole |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2015-07-01
- Completion
- 2015-07-01
- First posted
- 2015-03-30
- Last updated
- 2017-03-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02402595. Inclusion in this directory is not an endorsement.